Stay updated on Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial
Sign up to get notified when there's something new on the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page.

Latest updates to the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new Locations section has been added to the page, showing None - Non-US/Canada as locations. The HHS Vulnerability Disclosure link has been removed.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedPublications section updated to specify that publications provided by the study submitter are about the results of the study, and a new revision tag v3.3.2 was added.SummaryDifference0.1%

- Check52 days agoChange DetectedDeleted the administrative banner about a lapse in government funding and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check66 days agoChange DetectedNo additions or deletions were observed; the page content remains unchanged.SummaryDifference0.4%

- Check95 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference2%

- Check102 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page.